Tuesday, 19 February 2019

Personal Care Ingredients Market Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

This Personal Care Ingredients Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major regions such as Europe, North America, China, Japan, Southeast Asia and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report.
Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/245199

In this study, the years considered to estimate Personal Care Ingredients Market size to grow from XX Million in 2018 to XX Million by 2026, at an estimated CAGR of XX%:

Initial Year: 2018
Historic Year: 2014 - 2018
Projected Year: 2019
Forecast Year: 2019 - 2026

Personal Care Ingredients market report covers the Key Players' data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Major Players operating in market includes: Asahi Glass, Central Glass, Nippon Sheet Glass, Saint-Gobain, SCHOTT, Bendheim Glass, China Glass Holdings, CHINA YUTIAN HOLDINGS, DB Glass, Glaz-Tech Industries, GUARDIAN GLASS, Sisecam Group, Vitro Architectural Glass, Xinyi Glass among others

This Personal Care Ingredients market report also covers segment data, including: type segment, industry segment etc. cover different segment market size. Also cover different industries clients' information, which is very important for the Key Players.

Personal Care Ingredients Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Get discount on this report : https://www.worldwidemarketreports.com/discount/245199

Key Reasons to Purchase:
1) To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
2) Assess the production processes, major issues, and solutions to mitigate the development risk.
3) To understand the most affecting driving and restraining forces in the Personal Care Ingredients market and its impact in the global market.
4) Learn about the Personal Care Ingredients market strategies that are being adopted by leading respective organizations.
5) To understand the future outlook and prospects for the market during years 2019-2026.
In the end, Personal Care Ingredients market report provides valuable information for companies like manufacturers, suppliers, distributors, traders, customers, investors and individuals who have interests in this industry.
About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com
Posted by at No comments:
Labels: , ,

Tuesday, 25 July 2017

Hyperbaric Oxygen Therapy (HBOT) Devices Market Size ,Share and Forecast uoto 2025

Hyperbaric oxygen therapy (HBOT) devices are used to deliver 100% pure oxygen to tissues in the body under high atmospheric pressure. During HBOT, the pressure is increased to three times the normal atmospheric pressure, creating high amount of partial pressure of oxygen. Under normal conditions, one atmosphere absolute are subjected to be around 14.7 pounds per square inch of pressure and the air we normally breathe is composed of 21% oxygen and 79% nitrogen. Breathing in 100% oxygen, the body is exposed to rise in atmospheric pressure, the oxygen molecules become condensed and this allows to breathe a higher amount of partial pressure of oxygen, where in turn oxygen dissolves in the plasma around 10 to 15 times greater than normal. This super-saturation of oxygen in the body’s tissues promotes the increase in capillary growth, increase in white blood cell (WBC) activity, new tissues development, increase oxygen tension in hypoxic areas, reduction in the size of gas bubbles and numerous other physiological effects.
HBOT devices play a vital role in the field of medicine, these devices help in the treatment of many diseases such as asthma, HIV/AIDS, bell’s palsy, Parkinson’s disease, spinal cord injuries, hepatitis, migraines, multiple sclerosis, stroke and sport injuries. Moreover, HBOT devices have Food and Drug Administration (FDA) approval for treating decompression sickness, thermal, necrotizing soft tissues infection and burn injury. HBOT devices are also used in the off-label (means the medication is not specified in the FDA's approved packaging label) medical induction treatment such as brain injuries and cancer. Such high preference from the patients and physicians for HBOT in medical field has powered growth in the HBOT devices market. The market is expected to rise in the forecast period, especially across the North America, Europe and Asia-Pacific region.
Hyperbaric oxygen therapy (HBOT) devices market by taxonomy
Hyperbaric Oxygen Therapy Devices Market, by Product Type:
  • Monoplace HBOT Devices
  • Topical HBOT Devices
  • Multiplace HBOT Devices
by Application:
  • Wound Healing
  • Decompression Sickness
  • Infection Treatment
  • Gas Embolism
  • Others
by Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
Increase in number of wound healing treatment and cosmetic procedures is expected to support the growth of hyperbaric oxygen devices market
The growth in usage of hyperbaric oxygen therapy in healing of wound and cosmetic procedure is one of the factor to rise in demand in forecast period and also the rise in healthcare costs, increase in prevalence of diseases such as asthma, diabetes, and growth rate in aging population are some of the factors that can be accounted for the largest market share. Asia Pacific market is expected to grow in the forecast period due to the increase in income, growth in medical tourism industry, and rise in public awareness benefits HBOT devices.
People who are suffering from diabetes are at increased risk for a wound development. According to the Center for Disease Control and Prevention (CDC) in the U.S., it was diagnosed that around 21.0 million people suffered from diabetes in 2014. The U.S. is expected to be the growth engine of the global HBOT market through the forecast period. This is mainly attributed to increase in incidence rate of diabetes, and rising chronic disease and acute wounds and simultaneously growth in treatment rate due to the developed healthcare technology, healthcare expenditure by the government and high disposable income are some of the factors that are expected to support the market in future near.
As per The American Society of Plastic Surgeons (ASPS) around 15.9 million minimally invasive cosmetic procedures were performed in 2014-2015 in the U.S. Moreover, increasing number of metrosexual men is in turn expected to create a highly conducive environment for growth of the HBOT market.
Key players in the market:
  • Fink Engineering
  • HAUX-LIFE-SUPPORT
  • Gulf Coast Hyperbarics, Inc.
  • IHC Hytech B.V. (Royal IHC)
  • HEARMEC; Hyperbaric
  • Sechrist Industries, Inc.
  • OxyHeal International
  • Haux-Life-Support GmbH
  • HYPERBARIC S.A.C.
  • Hyperbaric Technology (HyTech) B.V.
  • Sands Hyperbaric Corporation
  • SOS Medical Group Ltd.
  • Hearmec Co., Ltd. and Fink Engineering Pty. Ltd.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Autoimmune Disease Diagnostics Market Size ,Share and Forecast upto 2025

The immune system of human body recognize some invaders such as bacteria, viruses, and external chemicals and attacks those to protect the body. However, sometimes the immune system attacks the healthy cells of body by considering them as foreign cells. Such a condition is called autoimmune disease. The autoimmune disease causes abnormal organ growth and changes in organ function. The genes of an individual with environmental exposure might be the major reason for autoimmune disease development. Some of the common autoimmune diseases among over 80 types of autoimmune diseases are type 1 diabetes, systemic lupus erythematosus, inflammatory bowel disease, rheumatoid arthritis. The curing therapy for autoimmune diseases is not yet available only relieving treatments are available for this diseases. Diagnosis of the autoimmune diseases can be done by the tests which involves antinuclear antibody test, antibody test, complete blood counts and some others.
Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/419
The growing incidences of autoimmune diseases and government initiatives to boost the autoimmune disease diagnostics market
According to American Autoimmune Related Disease Association (AARDA), in 2016, around 50 million people suffered from autoimmune diseases in the U.S. with 75% being women. Increasing incidence of autoimmune diseases, rising public awareness and government initiatives taken to spend the budget on diagnosis and care services for autoimmune diseases, are some of the factors which are driving the autoimmune disease diagnostics market. Many of the organizations and governments are funding the research and development program for autoimmune diseases, this will help to launch the new products in the market and definitely help in the growth of autoimmune disease diagnostics industry. For instance, the discovery of novel biomarkers, which has proven to be significant to improve the diagnosis of autoimmune diseases is also one of the major factor driving the autoimmune diseases diagnostic market.
Despite of all the driving factors for the autoimmune disease diagnostics market there are some restraints which slowing down the market such as, high rate of false results, slow turnaround time for test results and lack of experience and education of laboratory personnel in the diagnostics of certain autoimmune diseases.
Aging population and technological advancements in diagnosis of rheumatoid arthritis will be the cause of growth for rheumatoid arthritis segment
The global autoimmune disease diagnostic market are segmented on the basis of disease type, test type, end user and geography
On the basis of disease type, the autoimmune disease diagnostic market is segmented into:
  • Systemic Autoimmune Disease diagnostics
  • Rheumatoid Arthritis
  • Ankylosing Spondylitis
  • Systemic Lupus Erythematosus
  • Some Others
  • Localized autoimmune disease diagnostics
  • Multiple Sclerosis
  • Type 1 diabetes
  • Hashimoto’s thyroiditis
  • Idiopathic Thrombocytopenic purpura
The high patient awareness level and large procedure volumes are the reasons that localized autoimmune disease diagnostics is dominating the overall market. Though the initiatives taken by government for patients suffering from rheumatoid arthritis and systemic lupus erythematosus will aid in the growth of systemic autoimmune disease diagnostics segment.
On the basis of test type, the global autoimmune disease diagnostic market is segmented into:
  • Antinuclear Antibody Tests
  • Autoantibody Tests
  • Complete Blood Count
  • C-reactive Protein
  • Others
On the basis of end user, the global autoimmune disease diagnostics market is segmented into
  • Hospitals
  • Diagnostics Centers
  • Research Laboratories
The technological advancements in the North America region driving the autoimmune disease diagnostics market
The regional segmentation of autoimmune disease diagnostics market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Africa and rest of the world. North America is of the largest revenue contributor in the global autoimmune disease diagnostics industry. This is mainly attributed to rising incidence of some of the common autoimmune diseases like rheumatoid arthritis and type1 diabetes. The increase in funding by government and private sector, increasing regulatory scenario monitored by World Health Organization (WHO), and technological advancements are some of the factors which are driving growth of the autoimmune disease diagnostics market in the North America region. Asia Pacific is projected to be a fast emerging region in the global autoimmune disease diagnostic market.
The introduction of novel biomarkers in the market will aid in the growth of autoimmune disease diagnostic market
The key players operating the autoimmune disease diagnostics market are Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Euroimmun, Inova Diagnostics, Roche Diagnostics, Siemens Healthcare, A. Menarini Diagnostics, Adaptive Biotechnologies, AESKU Diagnostics, and many others. The government agencies of various countries are increasing their healthcare spending to provide better health care services, and the introduction of novel biomarkers in the research area, owing for ample opportunity for the key players, which in-turn will boost the autoimmune diseases diagnostic market.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Antibody Drug Conjugates Market Size , Share and Forecast upto 2024

Antibody drug conjugate is a significant class of highly potent bio drugs envisioned as a broad therapy for treatment of cancer. Unlike chemotherapy, antibody drug conjugate are proposed to mark and kill only cancer cells. Antibody drug conjugates are compound molecules that comprise antibodies linked to a biologically active cytotoxic drug.
By uniting the exclusive targeting capacities of mAB with anti-cancer drugs, ADCs allow for subtle judgment between healthy and diseased tissue. This entails that the antibody drug conjugates kill only cancer cells and ensure that other dynamic cells are less severely affected. This exceptional phenomenon of killing only cancer cells increase the importance of use of ADCs, which would indirectly boost growth of the global antibody drug conjugates market.
Commercialization of 7-10 ADCs in the following decade, would lead to revenue to surge to over US$ 10 billion over the forecast period of market
In terms of marketing, three antibody drug conjugates have received regulatory approval. The U.S. FDA approved one of the ADC in 2001 manufactured and developed by Pfizer/Wyeth, to treat acute myelogenous leukemia. The drug was subsequently withdrawn in June 2010, leaving only two antibody drug conjugates in the market. The two drugs marketed for ADCs are Brentuximab vedotin and Trastuzumab emtansine, developed and manufactured by Seattle Genetics and Millennium/Takeda and Genentech and Roche, respectively. Around 45 antibody drug conjugates molecules are under clinical trials, with the preclinical pipeline expanding at a high rate. Of all the 45 molecules, around 25% are under Phase II or Phase III of development. Frequently used cytotoxins for antibody drug conjugates under trials include auristatin, calicheamicin, maytansine and duocarmycin. Auristatin is the dominant compound accounting for over 50% of antibody drug conjugates in clinical development. Roche has 10 compounds under clinical trials, and this is the most developed pipeline of antibody drug conjugates. Globally, 70%-80% of antibody drug conjugates manufacturing is currently outsourced. There are limited number of contract manufacturers that have high-end manufacturing equipment for development of cytotoxins.
Antibody drug conjugates market is still in its infancy, with two approved ADCs to propel the market to two digit billion dollar mark by 2020
The global antibody drug conjugates market is segmented on the basis of drug and geography. On the basis of drug, the market is divided into Adcetris and Kadcyla.
Major pharmaceutical company opt for contract manufacturer for development and manufacture of antibody drug conjugates
Regional segmentation of the antibody drug conjugates market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Europe accounts for the largest share in the global market mainly due to presence of many contract manufacturing companies with advanced manufacturing equipment. Lonza is one of the top contract manufacturing companies in Europe, which has operations across France and Germany, with its headquarters in Switzerland. One of the facilities operated by the company is a deck to chemical manufacturing capabilities and develop peptides, small molecule active pharmaceutical ingredients, highly potent active pharmaceutical ingredients, cytotoxics agents, antibody drug conjugates, and microbial products. The company also offer proficiency in chemical, pharmaceutical, agrochemical and food industries by providing clients with yields such as high-class active substances, organic chemicals and intermediates.
Large number of clinical trial molecules in pipeline to boost growth of antibody drug conjugates market
Key players operating the antibody drug conjugates market include Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, and Progenics Pharmaceuticals. Major companies in the antibody drug conjugates industry are constantly working on research and development, as the market is largely untapped and offer highly lucrative growth opportunities. For instance, there are only two antibody drug conjugates available worldwide that are used to treat cancer, and there are over 40 molecules under clinical trials. Considering the alarmingly high incidence rate of cancer across the globe, the antibody conjugates market is expected to ride on a wave of positive growth in the foreseeable future.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Monday, 24 July 2017

Cryptococcosis Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

Cryptococcosis or cryptococcal disease is a fungal disease, which in severe cases can be fatal. It is caused by either Cryptococcus neoformans or Cryptococcus gattii. Cryptococcosis is said to be acquired by inhaling contagious propagule from surroundings. Even though the accurate character of the contagious propagule is not known, the primary theory is the basidiospore produced in the course of sexual or asexual reproduction is the cause. Cryptococcosis disease symptoms include fatigue, fever, headache, blurred vision, dry cough, and confusion. Symptoms onset is often subacute, worsening progressively over more than a few weeks. The two key complications of the disease are meningitis (brain infection) and pulmonary infection or lung infection. The occurrence of cryptococcosis is increasing over the years for various reasons, such as increase in prevalence of AIDS as well as extended use of immunosuppressive drugs. These factors are likely to propel the growth of the overall cryptococcosis treatment market in the near future.
According to a report by National Centre for Biotechnology Information, illnesses due to Cryptococcus fungi occur on a global scale and in an extensive range of hosts, starting from patients who are strictly immunosuppressed to patients with normal immune systems. The Centers for Disease Control and Prevention (CDC) states that around 1 million cryptococcosis cases arise throughout the globe, and it is anticipated that annually, the number of deaths associated with cryptococcosis is around 650,000. Most of the cases are reported among amongst patients with complex HIV disease. However, incidence rate is high amongst the recipients of solid organ transplant and patients getting exogenous immunosuppression. Cryptococcus occurs in those with acquired and innate immunodeficiency as well.
As the AIDS population is rising at a startling rate, the likelihood of occurrence of the disease is rising proportionately. Since cryptococcosis disease is communicable in nature, and it gets transmitted from one affected person to the next, persons suffering from the disease are expected to rise in the near future. Therefore, the cryptococcosis treatment market will also show a considerable growth.
Cryptococcosis Treatment Market Taxonomy
On the basis of type of treatment, global cryptococcosis treatment market is classified into:
    • Amphotericin B
    • Flucytosine
    • Fluconazole
    • Others
Rising prevalence of chronic diseases to fuel cryptococcosis treatment market growth
The major factor working for the increase of the worldwide cryptococcosis treatment market is the rising count of people being contaminated by the disease. As per UNAIDS, there is an estimated 36.7 million cases of AIDS in the world at the end of the year 2015. Rise in the prevalence of diseases such as AIDS will further amplify the demand for the cryptococcosis treatment. Cryptococcosis was classified as a rarely happening illness; however, now the disease is seen to be rising across the globe. Several governments are vastly interested in eliminating the disease altogether from their respective nations. The efforts put in by governments of various regions are encouraging the players in the global market to increase their overall spend on research and development activities, in order to get superior treatment alternatives. This will further aid the global market of cryptococcosis treatment to increase at a steady pace.
Increasing prevalence of cryptococcosis in Sub-Saharan Africa will drive the overall cryptococcosis treatment market growth
According to CDC, in 2009, there were an estimated 720,000 cases of HIV related cryptococcosis in the Sub-Saharan Africa, which is about three times the prevalence of the disease in all other parts of the world, combined. It is believed that the disease kills more people in this region than tuberculosis. Moreover, CDC also states that cryptococcosis is the fourth most fatal disease in the region. It is estimated to cause about 504,000 deaths per year. The occurrence of cryptococcosis in the region is growing at an alarming rate; hence, the market in this region is expected to grow at a significant rate over the forecast period.
Some of the major companies operating in the global cryptococcosis treatment market are Bristol-Myers Squibb Company, Sigmapharm Laboratories LLC, Janssen Biotech, Inc. (Johnson & Johnson), Novartis AG, Abbott Laboratories, Valeant Pharmaceuticals, Inc., Pfizer, Inc., and Glenmark Pharmaceuticals.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702

Posted by at No comments:
Labels: , ,

Medicinal Cannabis Market- Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016-2024

Medicinal cannabis market Overview:
Medicinal cannabis, also known as medicinal marijuana, is used either to treat disease or improve symptoms. Cannabis has been considered to be a major source of drug addiction. Extract from the dried flower bud part of the plant called as Marijuana has certain medicinal properties. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are being used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.
Medicinal Cannabis Market Dynamics
However, the debate still continues regarding the approval, safety and usage of cannabis (marijuana) for medicinal purpose, due to differences in the laws pertaining to this smoked drug. Hence, studies are conducted extensively to establish the safety aspect of this drug. Various states in the U.S. have already legalized cannabis (marijuana) for medicinal purposes. Scientific research of chemicals in the cannabis plant for its potential medicinal use has led to a shift in its demand purpose. Regulatory clearance has played a major role in the growth of medicinal cannabis market.
Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/40
Other names of Cannabis- grass, pot, dope, Mary Jane, hooch, weed, hash, joints, brew, reefers, cones, smoke, mull, buddha, ganga, hydro, yarndi, heads, and green.
The U.S. FDA has approved two medications, Marinol and Syndros, which contain dronabinol in pill form. However, the FDA has not approved the marijuana plant as a medicine. The medicinal cannabis (marijuana) is administered in either of the ways – liquid extract, vaporized form, smoked or solid form.
Prevalent Scenario in the Medicinal Cannabis Market
According to the Medical Marijuana, Inc., the estimated size of the legal marijuana industry in the U.S. is US$ 7.1 billion in 2016. This is an increase of 25% Y-o-Y. As of 2016, 28 states in the U.S. have legalized marijuana for medicinal purpose with some more gearing up for votes on the recreational use of marijuana. California, Nevada, Maine, and Massachusetts states in November 2016, voted to legalize the recreational use of marijuana. The accelerated pace of legalization of cannabis (marijuana) in the U.S. has attracted the attention of global investors in the medicinal cannabis market. However, lack of formulation of a comprehensive law pertaining to medicinal marijuana in some states inhibits patient access to the drug.
Important role of Regulatory Authorities in the Medicinal Cannabis Market Trends
According to the United Nations, marijuana was the most widely used drug globally in 2014, with around 183 million users. Such a large user base makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding legalization of the drug for medicinal use. The National Institute on Drug Abuse is still conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune disease, pain, inflammation, seizures, mental disorders, and substance abuse disorders. Regulatory compliance is a key factor that influences cost, quality, and safety of cannabis (marijuana) medicines, as well as the capacity for the manufacturers in the medical cannabis market to be responsive, scalable, and innovative.
Medicinal Cannabis Market Future Outlook
Potential medicinal cannabis markets other than the U.S., include Canada, Israel, Australia, and Spain. Mexico is also in process to consider the legalization of cannabis. Other countries are expected to consider legalization of the drug, once conclusive evidence regarding the safety and efficacy of cannabis are obtained through extensive research. According to Arcview Group—a cannabis industry investment and research firm—around 200 investors met companies to capitalize on lucrative opportunities from commercialization of medicinal cannabis. This implies that there is a huge potential in the medicinal cannabis industry and pharmaceutical and biotechnology companies need to focus on increasing awareness about the drug emerging economies.
About Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com
Posted by at No comments:
Labels: , ,

Colostomy Bags Market Size, Share and Forecast upto 2025

Colostomy is a surgical procedure in which an opening is formed by drawing the healthy end of the large intestine or colon by an incision in the anterior abdominal wall and then suturing and setting it into place. This helps the patient in better bowel motions through the stoma and collected in special disposable colostomy bag, which fits over the stoma and sticks to the skin. Colostomy can be permanent or temporary, as colostomy can be reversed by joining two ends together. Colostomy bags market is gaining traction due to increasing prevalence of diseases such as irritable bowel syndrome, multiple sclerosis, Crohn’s disease and cancer. Besides these colostomy can be performed due to birth defects or accidental injury. The broad spectrum regarding the causes for the disease is expected to favor the growth in colostomy bags market in the near future.
Colostomy bags market is backed by some of the factors as they does not bring significant changes in lifestyle as most of the people are allowed to follow the diet as earlier and perform their daily routine after the surgery. Furthermore, to avoid infections around colostomy bag due to spillage of stool, sweating, dislocation of colostomy bags wide range of accessories are provided, which includes support belts, girdles, deodorizers, skin protective wipes and stoma paste. Moreover, there are different types of colostomy bags such as closed bags, drainable bags, one piece system and two-piece system that are designed according to patients need.
Fill the form for an exclusive sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/503
Colostomy bags market taxonomy
By Product Type
  • Closed Pouch
  • Drainable Pouch
  • Two-Piece System
  • One-Piece System
By End Users
  • Hospital
  • Ambulatory Surgical Centers
  • Homecare Settings
Rise in incidence of Crohn’s disease and bowel cancer is expected to fuel the growth of colostomy bags market in the near future
Crohn’s disease is a type of inflammatory bowel disease (IBD) which can affect any part of gastrointestinal tract from mouth to anus which increase the market of colostomy bags. According to Centers for Disease Control and Prevention (CDC), 1.0-1.3 million people suffer from inflammatory bowel disease (IBD) as Crohn’s disease is more common in smokers. Whereas each year in the U.S. around 54,000 men and 17,000 women get bladder cancer according to Centers for Disease Control and Prevention (CDC), which significantly supports the rise in growth percentage of colostomy bags industry. The statistics provided above are expected to be a set of crucial factors that supports the growth in colostomy bags market over the forecast period.
Regional growth engines of the colostomy bags market
On the basis of regional segmentation, the global colostomy bags market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The global market is projected to show growth expansion in Asia Pacific due to the rise in incidence of colorectal cancer, increase in aging population and increase in medical tourism. According to Centers for Disease Control and Prevention (CDC) report in 2014, the highest incidence of colorectal cancer was reported in Asia Pacific and Hispanic with approximately 35 people out of 100,000 in 2013.
The key players dominating the global colostomy bags market
Providers in the market offer a broad range of colostomy bags and accessories and in increase in adoption of market strategies such as online marketing due to advanced technology to manufactures innovation in product competition in market is increasing. The key players operating the market of colostomy bag includes, Coloplast, ConvaTec, TG Eakin Hollister, Marlen, B. Braun Oakmed, and Welland Medical.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702



Posted by at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)